Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis

被引:26
作者
Chen, L
Martinez, O
Venkataramani, P
Lin, SX
Prabhakar, BS
Chan, LS
机构
[1] Univ Chicago, Coll Med, Dept Dermatol, Chicago, IL 60637 USA
[2] Univ Chicago, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60637 USA
[3] VA Jesse Brown Med Ctr, Med Serv, Chicago, IL USA
关键词
atopic dermatitis; animal model; T cells; antigen-presenting cells; proliferation;
D O I
10.1111/j.1365-2249.2004.02691.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Atopic dermatitis is a chronic inflammatory skin disease characterized by inflammatory cell infiltration in the skin. In order to assess the roles of inflammatory cells in this disease, we analysed the activation status and surface markers of various leucocytes in the IL-4 transgenic mouse model of atopic dermatitis, by flow cytometry, immuofluorescence microscopy, and T cell proliferation assays. The studies were performed with a nontransgenic mouse control and transgenic mice at three disease stages: before disease onset, early skin disease, and late skin disease, so that we can delineate the immunological sequence of events. As the skin disease evolves, the skin draining lymph node cells from IL-4-Tg mice show a spontaneous proliferation and a progressively enhanced proliferative response to stimulants including anti-CD3, Con A, PHA, and Staphylococcus enterotoxins A and B. As the disease evolves, the percent of lymphoid organ T cells expressing activation molecules (CD44 and CD69) and costimulatory molecules (ICOS and PD-1) are progressively increased; the percent and total number of T cells are reduced in an incremental manner in the secondary lymphoid organs while the number of T cells infiltrating the skin increases in an incremental fashion; the total number of dendritic antigen presenting cells, macrophages, and NK cells gradually increases in the lymphoid organs. Collectively, our results suggest that there is a continued and progressive migration of activated inflammatory cells from the secondary lymphoid organs into the skin where they participate in immune responses resulting in the pathology associated with inflammation.
引用
收藏
页码:189 / 201
页数:13
相关论文
共 43 条
[1]  
BRAATHEN LR, 1985, ACTA DERM-VENEREOL, P133
[2]   PREDOMINANCE OF T LYMPHOCYTES IN THE DERMAL INFILTRATE OF ATOPIC-DERMATITIS [J].
BRAATHEN, LR ;
FORRE, O ;
NATVIG, JB ;
EGLARSEN, TE .
BRITISH JOURNAL OF DERMATOLOGY, 1979, 100 (05) :511-519
[3]   Proliferation and production of interferon-gamma (IFN-gamma) and IL-4 in response to Staphylococcus aureus and Staphylococcal superantigen in childhood atopic dermatitis [J].
Campbell, DE ;
Kemp, AS .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (02) :392-397
[4]   The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].
Carreno, BM ;
Collins, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53
[5]   The expanding world of co-stimulation: the two-signal model revisited [J].
Chambers, CA .
TRENDS IN IMMUNOLOGY, 2001, 22 (04) :217-223
[6]   Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: An experimental animal model to study atopic dermatitis [J].
Chan, LS ;
Robinson, N ;
Xu, LT .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (04) :977-983
[7]   Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model [J].
Chen, L ;
Martinez, O ;
Overbergh, L ;
Mathieu, C ;
Prabhakar, BS ;
Chan, LS .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (03) :375-387
[8]   ATOPIC-DERMATITIS - RECENT TRENDS IN PATHOGENESIS AND THERAPY [J].
COOPER, KD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (01) :128-137
[9]   Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vβ-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes [J].
Davison, S ;
Allen, M ;
Vaughan, R ;
Barker, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02) :181-186
[10]  
Dong HD, 1999, NAT MED, V5, P1365